Response Genetics Inc. Enters Into Asset Purchase Agreement With Cancer Genetics Inc.; Proposed Transaction to be Effectuated Through Voluntary Chapter 11; Business Uninterrupted
August 10, 2015 08:50 ET
|
Response Genetics, Inc.
LOS ANGELES, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (OTCQB:RGDX) (the "Company"), a company focused on the development and sale of molecular diagnostic tests that help determine a...
Response Genetics, Inc. Announces First Quarter 2015 Financial Results
May 14, 2015 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, May 14, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. to Release First Quarter 2015 Financial Results and Host Conference Call on May 14, 2015
May 07, 2015 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, May 7, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response...
Response Genetics, Inc. Announces Fourth Quarter and Year-End 2014 Financial Results
March 31, 2015 16:05 ET
|
Response Genetics, Inc.
LOS ANGELES, March 31, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. to Release Fourth Quarter and Year-End 2014 Financial Results and Host Conference Call on March 31, 2015
March 19, 2015 14:07 ET
|
Response Genetics, Inc.
LOS ANGELES, March 19, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium 2015
January 15, 2015 14:10 ET
|
Response Genetics, Inc.
LOS ANGELES, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics Secures New York State Department of Health Approval for the Company's ResponseDX(R) Testing Services
December 11, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Third Quarter 2014 Financial Results
November 13, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. to Release Third Quarter 2014 Financial Results and Host Conference Call on November 13, 2014
November 06, 2014 13:03 ET
|
Response Genetics, Inc.
LOS ANGELES, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics Combines Cost-Effective, Rapid Turnaround Time With Next Generation Sequencing in Novel Lung Testing Offering
September 15, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Sept. 15, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has...